News Summary: Lower sales hurt Pfizer's 4Q net

Published on NewsOK Modified: January 28, 2014 at 12:21 pm •  Published: January 28, 2014
Advertisement
;

THE RESULTS: Pfizer beat Wall Street's fourth-quarter expectations for revenue and adjusted earnings per share, reporting $13.56 billion and 56 cents per share. Net income fell 59 percent to $2.57 billion.

THE PRESSURES: Generic competition continues to erode sales of drugs that once brought in billions, with another $3 billion in revenue losses expected in 2014. Income from partnerships is falling as a couple wind down. Unfavorable currency exchange rates add to that.

THE FUTURE: Key testing data due this year on experimental breast cancer and other drugs, plus other advances in Pfizer's pipeline, could boost share prices.


Advertisement


Trending Now



AROUND THE WEB

  1. 1
    Sixth-grade teacher arrested on sexual-assault complaint
  2. 2
    CTB/McGraw-Hill executives apologize for testing problems
  3. 3
    Oklahoma City Thunder: Russell Westbrook refuses to call FedEx Forum 'Grindhouse'
  4. 4
    Woman Admits to Taking Toy from Child's Grave
  5. 5
    Three Sexual Abuse Lawsuits Against Elmo Puppeteer Kevin Clash Dismissed
+ show more